Duke Precision Medicine Program Forum Series
Taking place the 2nd and 4th Thursday of each month from 12 - 1 p.m. EST on Zoom
"Factors predicting who will stick with a lifestyle intervention: Utilizing precision medicine to improve healthy lifestyle behaviors"
Katherine Collins, PhD
Duke Molecular Physiology Institute
Precision Medicine Program T32
Thursday, May 25, 2023
12 p.m. – 1 p.m.
Michael Kelley, MD, is a Professor of Medicine at Duke University and Chief of Hematology and Oncology at the Durham VA Medical Center. As Executive Director of the National Oncology Program for the Department of Veterans Affairs, Dr. Kelley directs policy, program development, and clinical operations that affect the more than 42,000 Veterans diagnosed with cancer each year in the nation’s largest integrated health care system. Dr. Kelley’s clinical practice is focused on lung cancer and precision oncology and his academic interests are in molecular genetics, experimental therapeutics of targeted therapies, and outcomes research. Dr. Kelley is the author of more than 130 peer-reviewed primary research articles as well as reviews, book chapters, and numerous meeting abstracts. He is a recipient of the US Public Health Service’s Achievement Award, a member of the National Cancer Institute’s Clinical Trials and Translational Research Advisory Committee, and an ex officio member of the National Cancer Advisory Board.
Save the date for the following talks!
- April 13: Kevin Shah, MD, Associate Professor of Medicine (General Internal Medicine), Duke Department of Medicine
- April 27: Michael Pencina, PhD, Vice Dean for Data Science, Duke University School of Medicine
- May 11: Olivia Dong, PhD, Senior Research Health Economist, RTI Health Solutions
- May 25: Katherine Collins, PhD, Postdoctoral Associate, Duke Molecular Physiology Institute, Precision Medicine Program T32